AMG:ETR
Amgen
329,95 €
arrow_downward
-0,68%(-2,25) 1d
18 de set., 14:50:36 GMT+2 · EUR
search
Tots els símbols
1d
5d
1m
6m
YTD
1a
5a
Màx.
| Símbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadístiques principals per a AMG...
Obre
330,60 €
Alt
331,45 €
Baix
329,95 €
Capitalització borsària
205,32 kM
Volum mitjà
447,00
Volum
111,00
Alt 52 setmanes
383,05 €
Baix 52 setmanes
230,55 €
Nombre d'empleats
32 k
Obre
330,60 €
Alt
331,45 €
Baix
329,95 €
Capitalització borsària
205,32 kM
Volum mitjà
447,00
Volum
111,00
Alt 52 setmanes
383,05 €
Baix 52 setmanes
230,55 €
Nombre d'empleats
32 k
Notícies
De fonts web i partners de notícies
Yahoo Finance
·
fa 13 hores
A Failed Cholesterol Drug Raises the Stakes for Amgen (AMGN) and Eli Lilly (LLY) Too
TipRanks
·
fa 20 hores
Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial
TIKR.com
·
fa 22 hores
Amgen Stock Fell 10% in a Day on a Drug It Doesn’t Own. Is It Time to Buy AMGN?
Investing.com
·
fa 23 hores
UBS lowers Amgen stock price target to $430 on drug trial concerns
Perfil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Sobre Amgen
Conseller delegatRobert A. Bradway
Empleats31,5 k
Fundació8 d’abr. 1980
Seu principalThousand Oaks, Califòrnia, Estats Units d'Amèrica
Sector-
Lloc webamgen.com